Chapter 3: Drug Interactions & Adverse Events in Therapeutics

Drug interactions are explored across four main categories: drug-drug, drug-food, complementary alternative medicine (CAM), and drug-disease interactions, all of which can significantly affect a drug's pharmacokinetic or pharmacodynamic profile. Pharmacokinetic changes are examined through absorption modifications (such as altered gastric pH or adsorption by cations), distribution shifts (like competition for protein-binding sites, crucial for highly bound drugs with narrow therapeutic indexes like warfarin), and alterations in excretion (including changes in urine pH or saturation of active transport pathways). Metabolism interactions are dominated by the Cytochrome P-450 (CYP) enzyme system, particularly the CYP3A4, 2D6, 2C9, 1A2, and 2C19 isoforms. Interactions here involve either inhibition, which increases drug concentrations and toxicity risk (e.g., ketoconazole and simvastatin), or induction, which decreases efficacy by speeding up metabolism (e.g., rifampin). The P-glycoprotein (P-gp) efflux transporter is also discussed for its role in modifying drug absorption and elimination. Pharmacodynamic interactions result when drugs with similar effects produce exaggerated responses (e.g., alprazolam and muscle relaxants) or when opposing actions diminish therapeutic effect (e.g., NSAIDs reducing diuretic action). Critical drug-food interactions include the inhibition of intestinal CYP3A4 by grapefruit juice, the chelation of antibiotics by milk products, and the serious hypertensive risk posed by MAO inhibitors combined with tyramine-rich foods. Patient-specific variables, including genetic polymorphisms in CYP enzymes, smoking, alcohol use (acute inhibition vs. chronic induction), and coexisting diseases affecting organ function (liver, kidney), determine an individual’s risk of interactions. Finally, the chapter addresses ADRs, classifying them as predictable Type A or unpredictable Type B reactions, and stresses the importance of understanding medication errors and utilizing reporting systems like MedWatch.